imported>Jimmy-bot：机器人: 尚未清空的已重定向分类）（Cat:狡詐家藥物→Cat:策划药

2025-08-15T10:24:33Z

机器人: 尚未清空的已重定向分类）（Cat:狡詐家藥物→Cat:策划药

新页面

{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 477235697
| IUPAC_name =(6aR,9R)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
| image = AL-LAD structure.svg
| width = 185


| legal_AU = Unscheduled 
| legal_CA = Unscheduled.
| legal_DE = NpSG
| legal_UK = Class A
| legal_US = Unscheduled, could be illegal if is sold for human consumption under the [[Federal Analogue Act]].
| legal_status = Illegal in [[Denmark]], [[Sweden]], [[Switzerland]] and [[France]], could be illegal in many countries if is sold for human consumption or under the several analogue acts<ref>{{cite web|date=20 May 2021|title=Arrêté du 20 mai 2021 modifiant l'arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants|trans-title=Order of May 20, 2021 amending the order of February 22, 1990 setting the list of substances classified as narcotics|url=https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000043523554|work=Journal officiel de la République française|language=fr|access-date=2024-10-06|archive-date=2023-02-07|archive-url=https://web.archive.org/web/20230207101535/https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000043523554|dead-url=no}}</ref>
| dependency_liability =
| routes_of_administration =


| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 65527-61-9
| ATC_prefix =
| ATC_suffix =
| ATC_supplemental =
| PubChem = 15227511
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 21106248
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 020O2SR91L
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 281787


| chemical_formula =
| C=22 | H=27 | N=3 | O=1
| smiles = [H][C@@]12Cc3c[nH]c4cccc(C1=C[C@@H](C(=O)N(CC)CC)CN2CC=C)c34
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H27N3O/c1-4-10-25-14-16(22(26)24(5-2)6-3)11-18-17-8-7-9-19-21(17)15(13-23-19)12-20(18)25/h4,7-9,11,13,16,20,23H,1,5-6,10,12,14H2,2-3H3/t16-,20-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = JCQLEPDZFXGHHQ-OXQOHEQNSA-N
| synonyms =
| density =
| melting_point =
| boiling_point =
| solubility =
| specific_rotation =
}}
'''{{PAGENAME}}'''（6-allyl-6-''nor''-LSD，6-烯丙基-6-去甲-LSD）是一种[[有机化合物]]，化学式为[[C22H27N3O|C22H27N3O]]，为[[迷幻药物]][[麥角酸二乙酰胺]]（LSD）的[[衍生物]]<ref>{{cite journal | vauthors = Brandt SD, Kavanagh PV, Westphal F, Elliott SP, Wallach J, Colestock T, Burrow TE, Chapman SJ, Stratford A, Nichols DE, Halberstadt AL | display-authors = 6 | title = 6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ) | journal = Drug Testing and Analysis | volume = 9 | issue = 1 | pages = 38–50 | date = January 2017 | pmid = 27265891 | pmc = 5411264 | doi = 10.1002/dta.1985 }}</ref>，最早由[[亚历山大·舒尔金]]在其著作《{{link-en|TiHKAL：延续|TiHKAL}}》（''TIHKAL: The Continuation''）中提出，可由{{lwd|Q63399972}}与[[烯丙基溴]]合成。

==参考文献==
{{reflist}}

==外部链接==
* [https://www.erowid.org/library/books_online/tihkal/tihkal01.shtml AL-LAD entry in TiHKAL] {{Wayback|url=https://www.erowid.org/library/books_online/tihkal/tihkal01.shtml |date=20250130064425 }}
* [https://isomerdesign.com/PiHKAL/read.php?domain=tk&id=1 AL-LAD entry in TiHKAL • info] {{Wayback|url=https://isomerdesign.com/PiHKAL/read.php?domain=tk&id=1 |date=20240505201907 }}
* [https://www.ukchemicalresearch.org/Thread-AL-LAD AL-LAD Thread at UKChemicalResearch.org] {{Webarchive|url=https://web.archive.org/web/20160808095211/https://www.ukchemicalresearch.org/Thread-AL-LAD |date=2016-08-08 }}

[[Category:策划药]]
[[Category:麦角酰胺]]
[[Category:血清素受体激动剂]]
[[Category:烯丙胺]]

AL-LAD - 版本历史

imported>Jimmy-bot：​机器人: 尚未清空的已重定向分类） （Cat:狡詐家藥物→Cat:策划药

imported>Jimmy-bot：机器人: 尚未清空的已重定向分类）（Cat:狡詐家藥物→Cat:策划药